Showing results (1-10 of 150) with videos related to
Sort By:
Pageof 15
Trends in Pharmacological Sciences|April 5, 2011
Anticancer therapy with checkpoint inhibitors: what, where and when?Michelle D Garrett, Ian CollinsCurrent Opinion in Pharmacology|June 21, 2005
Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitorsIan Collins, Michelle D GarrettNature Reviews. Cancer|November 16, 2007
CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?Laurent Antoni, Nayanta Sodha, Ian Collins, et al.Cancer Research|March 13, 2020
CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer CellsRebecca F Rogers, Michael I Walton, Daniel L Cherry, et al.Journal of Biomolecular Screening|August 12, 2006
Identification of small-molecule inhibitors of protein kinase B (PKB/AKT) in an AlphaScreenTM high-throughput screenSamantha Burns, Jonathan Travers, Ian Collins, et al.Cancer Research|April 5, 2015
Rho kinase inhibitors block melanoma cell migration and inhibit metastasisAmine Sadok, Afshan McCarthy, John Caldwell, et al.Anti-Cancer Agents in Medicinal Chemistry|January 20, 2009
Targeted small-molecule inhibitors of protein kinase B as anticancer agentsIan CollinsJournal of Medicinal Chemistry|April 25, 2007
Rapid evolution of 6-phenylpurine inhibitors of protein kinase B through structure-based designAlastair Donald, Tatiana McHardy, Martin G Rowlands, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Targeting the double-strand DNA break repair pathway as a therapeutic strategyChristopher J Lord, Michelle D Garrett, Alan AshworthThe Journal of Cell Biology|February 5, 2003
The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell densityMaria S Balda, Michelle D Garrett, Karl MatterPageof 15